Soligenix (SNGX)
NASDAQ:SNGX

Soligenix (SNGX) Stock Price & Analysis

527 Followers

SNGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $15.00
Previous Close$0.73
Volume212.29K
Average Volume (3M)872.10K
Market Cap
$5.88M
Enterprise Value$4.84M
Total Cash (Recent Filing)$10.27M
Total Debt (Recent Filing)$9.22M
Price to Earnings (P/E)-0.2
Beta0.60
Aug 10, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.65
Shares Outstanding8,115,854
10 Day Avg. Volume287,176
30 Day Avg. Volume872,103
Standard Deviation0.28
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.60
Price to Sales (P/S)22.88
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.13
Enterprise Value/Gross Profit12.16
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SNGX FAQ

What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $0.65 and its highest was $15.00 in the past 12 months.
    What is Soligenix’s market cap?
    Currently, no data Available
    When is Soligenix’s upcoming earnings report date?
    Soligenix’s upcoming earnings report date is Aug 10, 2023 which is in 75 days.
      How were Soligenix’s earnings last quarter?
      Currently, no data Available
      Is Soligenix overvalued?
      According to Wall Street analysts Soligenix’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Soligenix pay dividends?
        Soligenix does not currently pay dividends.
        What is Soligenix’s EPS estimate?
        Soligenix’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Soligenix have?
        Soligenix has 8,115,854 shares outstanding.
          What happened to Soligenix’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Soligenix?
          Currently, no hedge funds are holding shares in SNGX

          ---

          Soligenix Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -91.31%
          12-Months-Change

          Fundamentals

          Return on Equity
          -656.49%
          Trailing 12-Months
          Asset Growth
          -53.11%
          Trailing 12-Months
          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          Soligenix

          Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.

          ---

          Top 5 ETFs holding SNGX

          Currently, no data available
          Please return soon. This page is being updated.
          Up to five ETFs with an Outperform Smart Score that hold SNGX. The ETFs are listed according to market value of SNGX within the ETF

          ---

          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Company
          Price & Change
          Follow
          CASI Pharmaceuticals
          Spruce Biosciences
          Codiak BioSciences
          Inhibitor Therapeutics
          Marker Therapeutics

          Popular Stocks

          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis